Intuitive Surgical, Inc. (NASDAQ:ISRG) Holdings Raised by Invesco Ltd.

Invesco Ltd. increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 4,148,180 shares of the medical equipment provider’s stock after purchasing an additional 295,025 shares during the quarter. Intuitive Surgical makes up approximately 0.4% of Invesco Ltd.’s portfolio, making the stock its 27th largest position. Invesco Ltd.’s holdings in Intuitive Surgical were worth $2,165,184,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of ISRG. Howard Capital Management Group LLC lifted its holdings in Intuitive Surgical by 4.5% in the 3rd quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider’s stock worth $1,044,000 after purchasing an additional 92 shares during the last quarter. Principal Financial Group Inc. lifted its stake in Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider’s stock worth $295,938,000 after purchasing an additional 9,194 shares during the period. Kovitz Investment Group Partners LLC grew its position in Intuitive Surgical by 247.7% in the third quarter. Kovitz Investment Group Partners LLC now owns 7,451 shares of the medical equipment provider’s stock valued at $3,660,000 after acquiring an additional 5,308 shares during the period. Zacks Investment Management boosted its position in Intuitive Surgical by 3.2% in the third quarter. Zacks Investment Management now owns 30,196 shares of the medical equipment provider’s stock valued at $14,834,000 after buying an additional 928 shares in the last quarter. Finally, Orion Portfolio Solutions LLC boosted its holdings in shares of Intuitive Surgical by 22.0% in the 3rd quarter. Orion Portfolio Solutions LLC now owns 12,855 shares of the medical equipment provider’s stock worth $6,315,000 after acquiring an additional 2,315 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $451.58 on Monday. The stock has a market capitalization of $160.84 billion, a PE ratio of 70.45, a PEG ratio of 5.85 and a beta of 1.55. The business has a fifty day moving average price of $545.18 and a two-hundred day moving average price of $533.00. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00.

Insiders Place Their Bets

In related news, EVP Brian Edward Miller sold 8,900 shares of the business’s stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total value of $4,317,123.00. Following the sale, the executive vice president now owns 5,758 shares of the company’s stock, valued at $2,793,033.06. The trade was a 60.72 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent research reports. Raymond James raised their price target on Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Leerink Partners lifted their price objective on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Robert W. Baird dropped their price target on Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research note on Tuesday, March 18th. Jefferies Financial Group lifted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Finally, Citigroup lifted their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.